Tsavaris NB - Search Results

1

A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer.

Kosmas C, Tsavaris NB, Makatsoris T, Onyenadum A, Vadiaka M, Stavroyianni N, Sepsas E, Dimitropoulos D, Rokana S, Kalofonos HP. Kosmas C, et al. Among authors: tsavaris nb. Int J Cancer. 2002 Mar 1;98(1):141-7. doi: 10.1002/ijc.10162. Int J Cancer. 2002. PMID: 11857398 Clinical Trial.

2

Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy.

Tsavaris N, Kosmas C, Vadiaka M, Koufos C. Tsavaris N, et al. BMC Cancer. 2002;2:2. doi: 10.1186/1471-2407-2-2. Epub 2002 Jan 30. BMC Cancer. 2002. PMID: 11860608 Free PMC article. Clinical Trial.

3

Salvage chemotherapy with the gemcitabine/docetaxel combination in non-small cell lung cancer: an overview of recent phase II studies.

Kosmas C, Tsavaris N, Kalofonos HP. Kosmas C, et al. Med Sci Monit. 2002 Jun;8(6):PI58-63. Med Sci Monit. 2002. PMID: 12070450

4

An overview of current results with the gemcitabine and docetaxel combination as initial and salvage chemotherapy regimen in advanced non-small cell lung cancer.

Kosmas C, Tsavaris N, Mylonakis N, Kalofonos HP. Kosmas C, et al. Crit Rev Oncol Hematol. 2003 Mar;45(3):265-75. doi: 10.1016/s1040-8428(02)00081-1. Crit Rev Oncol Hematol. 2003. PMID: 12633839 Review.

5

A phase II study of the docetaxel-ifosfamide-carboplatin combination in advanced non-small-cell lung cancer.

Kosmas C, Tsavaris N, Koutras A, Makatsoris T, Mylonakis N, Tzelepis G, Dimitrakopoulos A, Spyropoulos K, Polyzos A, Karabelis A, Kalofonos HP. Kosmas C, et al. Oncology. 2005;69(4):333-41. doi: 10.1159/000089681. Epub 2005 Nov 9. Oncology. 2005. PMID: 16282711 Clinical Trial.

6

A phase II study of the docetaxel-carboplatin chemotherapy regimen in advanced non-small-cell lung cancer.

Tsavaris N, Kosmas C, Skopelitis E, Gennatas K, Zorbala A, Papas P, Gouveris P, Antypas G, Rokana S, Tzelepis G. Tsavaris N, et al. Lung. 2005 Nov-Dec;183(6):405-16. doi: 10.1007/s00408-005-2552-5. Lung. 2005. PMID: 16465600 Clinical Trial.

7

A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens.

Kosmas C, Tsavaris N, Syrigos K, Koutras A, Tsakonas G, Makatsoris T, Mylonakis N, Karabelis A, Stathopoulos GP, Kalofonos HP. Kosmas C, et al. Cancer Chemother Pharmacol. 2007 Jan;59(1):51-9. doi: 10.1007/s00280-006-0242-5. Epub 2006 Apr 19. Cancer Chemother Pharmacol. 2007. PMID: 16622691 Clinical Trial.

8

A simplified premedication protocol for one-hour paclitaxel infusion in various combinations.

Kosmas C, Tsavaris N. Kosmas C, et al. Med Sci Monit. 2006 Nov;12(11):CR462-6. Med Sci Monit. 2006. PMID: 17072270 Clinical Trial.

9

Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.

Tsavaris N, Kosmas C, Vadiaka M, Efremidis M, Zinelis A, Beldecos D, Sakelariou D, Koufos C, Stamatelos G. Tsavaris N, et al. Med Sci Monit. 2002 Jun;8(6):PI51-7. Med Sci Monit. 2002. PMID: 12070449

10

Etoposide added to weekly leucovorin (LV)/5-fluorouracil (5-FU) in LV/5-FU pre-treated patients with advanced colorectal cancer.

Tsavaris N, Kosmas C, Gennatas K, Vadiaka M, Paliaros P, Dimitrakopoulos A, Diamantis T, Tsipras H, Papastratis G. Tsavaris N, et al. Med Sci Monit. 2002 Sep;8(9):PI65-9. Med Sci Monit. 2002. PMID: 12218954 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters